your search results
Simply choose your interests by category and year. You can reduce your result list by deactivating categories you are not interested in.
- Articles in the press
- News
- Press releases
- Company news
Shaping the Consumer Healthcare Industry: a CEO’s Perspective on Innovation and the Future of Consumer Health in Europe
What is shaping Europe’s supplements market? In this Q&A with Nicholas Hall’s Insight Consumer Healthcare Europe, HERMES PHARMA CEO Dr. Jürgen Ott shares his perspective on consumer-led innovation, dosage form trends, and the regulatory shifts ahead.
HERMES PHARMA returns to CPHI Frankfurt as exhibitor
We are announcing our participation as exhibitor in the CPHI Worldwide which will be hosted in Frankfurt from October 28 to 30, 2025.At our stand 5.0C58 in hall 5.0 we will feature our user-friendly oral dosage forms such as orally disintegrating granules, chewable and effervescent tablets, instant drinks, and lozenges.Visitors to our stand will have the opportunity to explore how our solutions make medicines easier to take
Safety Meets Accessibility: Creating the Ideal Packaging for On-The-Go Dosage Forms
Our innovative stick packs combine child-resistant safety with senior-friendly accessibility. Engineered for modern patient needs, they enable precise, fast and water-free medication intake while preventing accidental openings. Read how our new laser-cut design meets international safety standards while ensuring convenience without compromise – article published in Contract Pharma.
Effervescent Evolution: New Technologies and Method Revitalize a Time-Tested Dosage Form
We have introduced a new advancement in effervescent tablet manufacturing. The patented manufacturing method not only enhances production efficiency, but also delivers excellent palatability while reducing environmental impact. The secured patent protection underscores HERMES PHARMA’s commitment to refining pharmaceutical delivery solutions while ensuring product exclusivity. Article published by Tablets & Capsules.
HERMES PHARMA Receives Recognition for Research Excellence from German Government
HERMES PHARMA has been awarded the BSFZ seal from the German Certification Office for Research Allowance. This recognition underscores our contributions to innovation in pharmaceutical manufacturing as well as our commitment to advancing healthcare solutions that benefit all – industry partners, patients and consumers.
Reducing Risk, Speeding Development — a CDMO Model Including GCP-Sponsorship to Better Meet the Needs of Pharma Companies
Pharmaceutical companies are under mounting pressure to develop more user-friendly products. Faced with fierce competition, they’re also demanding more CDMO support than ever. How does a new type of CDMO offering — one that takes on the responsibility of clinical trial sponsorship — de-risk and accelerate go-to-market? Read this Q&A with Drug Development & Delivery.